Intellia Therapeutics, Inc. - NTLA

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.515B
QoQ value delta ($000)
+$1.017B (+67.87%)
Implied price effect (QoQ)
+31.99%
Shares
Total shares
148,746,959
QoQ shares delta
+31,790,062 (+27.18%)
Total shares held by funds (by quarter)

Market chart (NTLA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 334 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
ARK Investment Management LLC 285,536 16,875,684 1.85%
BlackRock, Inc. 260,720 15,409,023 0.0%
STATE STREET CORP 156,255 9,234,987 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 124,064 7,332,401 0.01%
D. E. Shaw & Co., Inc. 109,021 6,443,323 0.05%
VANGUARD CAPITAL MANAGEMENT LLC 102,003 6,028,586 0.0%
TWO SIGMA INVESTMENTS, LP 88,582 5,235,348 0.06%
FMR LLC 80,759 4,773,034 0.0%
RA CAPITAL MANAGEMENT, L.P. 76,595 4,526,926 0.67%
REGENERON PHARMACEUTICALS, INC. 62,654 3,702,995 35.35%
GEODE CAPITAL MANAGEMENT, LLC 61,449 3,631,061 0.0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 55,510 3,280,760 0.02%
Sumitomo Mitsui Trust Group, Inc. 49,026 2,897,529 0.03%
Amova Asset Management Americas, Inc. 49,026 2,897,529 0.63%
DIMENSIONAL FUND ADVISORS LP 44,038 2,602,944 0.01%
UBS Group AG 41,394 2,446,500 0.01%
GOLDMAN SACHS GROUP INC 38,314 2,264,471 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36,453 2,154,479 0.0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 34,962 2,066,356 0.15%
Contrarius Group Holdings Ltd 33,082 1,955,228 1.52%
JUPITER ASSET MANAGEMENT LTD 31,293 1,849,507 0.16%
MORGAN STANLEY 29,303 1,731,905 0.0%
ARMISTICE CAPITAL, LLC 25,380 1,500,000 0.31%
RENAISSANCE TECHNOLOGIES LLC 23,688 1,400,004 0.03%
NORTHERN TRUST CORP 21,524 1,272,136 0.0%